ERBB2 and cancer: Single‐antibody‐functionalized 177Lu‐AuNP interacted only with cells expressing the corresponding receptor (HER2 or EGFR), whereas dual‐antibody‐functionalized 177Lu‐AuNP interacted with cancer cells expressing HER2, EGFR, and both receptors.